生物来源
rabbit
质量水平
偶联物
unconjugated
抗体形式
IgG fraction of antiserum
抗体产品类型
primary antibodies
克隆
polyclonal
表单
buffered aqueous solution
包装
antibody small pack of 25 μL
技术
indirect ELISA: 1:1,000 using 5 × 1010 phage/ml
运输
dry ice
储存温度
−20°C
靶向翻译后修饰
unmodified
正在寻找类似产品? 访问 产品对比指南
免疫原
fd 噬菌体
应用
B7786 兔抗 fd 噬菌体抗体可用于分类噬菌体展示文库（抗体、肽等），表达的蛋白与丝状噬菌体的基因 III 或基因 VIII 蛋白融合。该产品也可用于“噬菌体 ELISA”，提供重组噬菌体检测的特异性活性。当直接包被在微孔板上或作为特异性捕获的 fd 或 M13 噬菌体的一级检测抗体时，它也将起到捕获抗体的作用。
兔抗 fd 噬菌体抗体可按 1:1000 的稀释度用于 ELISA。它用于抗噬菌体免疫组化。
生化/生理作用
该抗体与 fd 噬菌体或 M13 噬菌体的噬菌体外壳蛋白特异性结合，因此当直接包被在多孔板上或作为特异性捕获 fd 或 M13 噬菌体的一级检测抗体时，可作为捕获抗体发挥作用。该抗体可用于快速分选大型噬菌体展示文库（抗体、肽等），所述表达蛋白与丝状噬菌体的基因 III 或基因 VIII 蛋白融合。该抗体可作为“噬菌体 ELISA”的检测试剂，为重组噬菌体的检测提供灵敏、特异的活性。
外形
0.01 M 磷酸盐缓冲盐水 (pH 7.4) 中提供的溶液，含 15 mM 叠氮化钠
制备说明
以 fd 噬菌体为免疫原，在家兔体内制备了抗 fd 噬菌体。分离全抗血清，然后通过离子交换色谱法进一步纯化，以提供基本上不含其他兔血清蛋白的抗血清的 IgG 组分。
免责声明
除非我们的产品目录或产品随附的其他公司文件中另有说明，否则我们的产品仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、体外或体内治疗用途或任何类型的人类或动物消费或应用。
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
12 - Non Combustible Liquids
WGK
nwg
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
常规特殊物品
此项目有
Paola A Bignone et al.
Methods in molecular biology (Clifton, N.J.), 1357, 269-283 (2014-11-21)
The ability of human pluripotent stem cells (hPS) to both self-renew and differentiate into virtually any cell type makes them a promising source of cells for cell-based regenerative therapies. However, stem cell identity, purity, and scalability remain formidable challenges that
Daniela I Staquicini et al.
Proceedings of the National Academy of Sciences of the United States of America, 118(30) (2021-07-09)
Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued.
Anne S Knudsen et al.
Scientific reports, 12(1), 3040-3040 (2022-02-25)
The pathogenesis of malaria is associated with blood-stage infection and there is strong evidence that antibodies specific to parasite blood-stage antigens can control parasitemia. This provides a strong rational for applying blood-stage antigen components in a multivalent vaccine, as the
Yasuto Akiyama et al.
Biomedical research (Tokyo, Japan), 35(2), 105-116 (2014-04-25)
Of all potential biological therapeutics, monoclonal antibody (mAb)-based therapies are becoming the dominant focus of clinical research. In particular, smaller recombinant antibody fragments such as single-chain variable fragments (scFv) have become the subject of intense focus. However, an efficient affinity
Mikhail G Kolonin et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 20(7), 979-981 (2006-04-04)
In vivo phage display is a technology used to reveal organ-specific vascular ligand-receptor systems in animal models and, recently, in patients, and to validate them as potential therapy targets. Here, we devised an efficient approach to simultaneously screen phage display
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持